stella
beta
Intratumoral and Systemic Hiltonol® (Poly-ICLC) in Prostate Cancer Patients on Active Surveillance — Stella
Recruiting
Back to Prostate Cancer Patients on Active Surveillance trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
United States
Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York
View full record on ClinicalTrials.gov